Pulmonx Corporation

Nasdaq LUNG · Redwood City, CA

Works in Respiratory

Pulmonx Corporation is a clinical trial sponsor based in Redwood City, CA, listed as Nasdaq LUNG. It has 3 active clinical trials with 490 planned participants, in Respiratory. Since 2021 it has completed 5 trials and stopped 0 early. Its FDA record on file shows 1 inspection.

Trial track record · since 2021

3Active trials490 planned participants
5Completed1 with results posted
0Stopped early0% of finished trials

FDA record

1InspectionLatest 2026-07-02: No action indicated
0Warning lettersNone on file
0RecallsNone on file

Recent FDA actions

Financials · Nasdaq LUNG

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 3 active trials

StageTrialStatus

Questions about Pulmonx Corporation

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2026-09-17.

The FDA record counts inspection classifications, warning letters and recalls FDA has published that name this company. Compare it with the industry in the free CDMO FDA inspection lookup.

Approve Suite is not affiliated with Pulmonx Corporation.

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.